Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions
File(s)s40478-017-0478-9.pdf (4.44 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Microtubule-associated protein tau aggregates constitute the characteristic neuropathological features of several
neurodegenerative diseases grouped under the name of tauopathies. It is now clear that the process of tau
aggregation is associated with neurodegeneration. Several transgenic tau mouse models have been developed where
tau progressively aggregates, causing neuronal death. Previously we have shown that transplantation of astrocytes in
P301S tau transgenic mice rescues cortical neuron death, implying that the endogenous astrocytes are deficient in
survival support. We now show that the gliosis markers Glial fibrillary acidic protein (GFAP) and S100 calcium-binding
protein B (S100β) are elevated in brains from P301S tau mice compared to control C57Bl/6 mice whereas the
expression of proteins involved in glutamine/glutamate metabolism are reduced, pointing to a functional deficit. To
test whether astrocytes from P301S mice are intrinsically deficient, we co-cultured astrocytes and neurons from control
and P301S mice. Significantly more C57-derived and P301S-derived neurons survived when cells were cultured with
C57-derived astrocytes or astrocyte conditioned medium (C57ACM) than with P301S-derived astrocytes or astrocyte
conditioned medium (P301SACM), or ACM from P301L tau mice, where the transgene is also specifically expressed in
neurons. The astrocytic alterations developed in mice during the first postnatal week of life. In addition, P301SACM
significantly decreased presynaptic (synaptophysin, SNP) and postsynaptic (postsynaptic density protein 95, PSD95)
protein expression in cortical neuron cultures whereas C57ACM enhanced these markers. Since thrombospondin 1
(TSP-1) is a major survival and synaptogenic factor, we examined whether TSP-1 is deficient in P301S mouse brains and
ACM. Significantly less TSP-1 was expressed in the brains of P301S tau mice or produced by P301S-derived astrocytes,
whereas supplementation of P301SACM with TSP-1 increased its neurosupportive capacity. Our results demonstrate
that P301S-derived astrocytes acquire an early functional deficiency that may explain in part the loss of cortical neurons
in the P301S tau mice.
neurodegenerative diseases grouped under the name of tauopathies. It is now clear that the process of tau
aggregation is associated with neurodegeneration. Several transgenic tau mouse models have been developed where
tau progressively aggregates, causing neuronal death. Previously we have shown that transplantation of astrocytes in
P301S tau transgenic mice rescues cortical neuron death, implying that the endogenous astrocytes are deficient in
survival support. We now show that the gliosis markers Glial fibrillary acidic protein (GFAP) and S100 calcium-binding
protein B (S100β) are elevated in brains from P301S tau mice compared to control C57Bl/6 mice whereas the
expression of proteins involved in glutamine/glutamate metabolism are reduced, pointing to a functional deficit. To
test whether astrocytes from P301S mice are intrinsically deficient, we co-cultured astrocytes and neurons from control
and P301S mice. Significantly more C57-derived and P301S-derived neurons survived when cells were cultured with
C57-derived astrocytes or astrocyte conditioned medium (C57ACM) than with P301S-derived astrocytes or astrocyte
conditioned medium (P301SACM), or ACM from P301L tau mice, where the transgene is also specifically expressed in
neurons. The astrocytic alterations developed in mice during the first postnatal week of life. In addition, P301SACM
significantly decreased presynaptic (synaptophysin, SNP) and postsynaptic (postsynaptic density protein 95, PSD95)
protein expression in cortical neuron cultures whereas C57ACM enhanced these markers. Since thrombospondin 1
(TSP-1) is a major survival and synaptogenic factor, we examined whether TSP-1 is deficient in P301S mouse brains and
ACM. Significantly less TSP-1 was expressed in the brains of P301S tau mice or produced by P301S-derived astrocytes,
whereas supplementation of P301SACM with TSP-1 increased its neurosupportive capacity. Our results demonstrate
that P301S-derived astrocytes acquire an early functional deficiency that may explain in part the loss of cortical neurons
in the P301S tau mice.
Date Issued
2017-11-29
Date Acceptance
2017-10-02
Citation
Acta Neuropathologica Communications, 2017, 5
ISSN
2051-5960
Publisher
BioMed Central
Journal / Book Title
Acta Neuropathologica Communications
Volume
5
Copyright Statement
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
License URL
Subjects
Astrocyte conditioned medium
Frontotemporal dementia
Neuroprotection
Neurotoxicity
Synaptic markers
TSP-1
Tau
Publication Status
Published
Article Number
89